Lung cancer is the third most frequent human malignant tumour and the leading cause of cancer‑associated mortality worldwide. Emerging lines of evidence have demonstrated that microRNAs (miRNAs) are upregulated or downregulated in non‑small cell lung cancer (NSCLC), and this phenomenon is involved in the regulation of various processes during tumorigenesis and progression, including tumour groWTh, apoptosis, cell invasion, and tumour metastasis. Therefore, understanding the molecular mechanism that associates abnormally expressed miRNAs with NSCLC formation and development may lead to the identification of novel diagnostic, and therapeutic targets for patients with NSCLC. miRNA‑584 (miR‑584) functions as a tumour suppressor in several types of cancer. However, the expression pattern, detailed biological function and underlying molecular mechanism of miR‑584 in NSCLC remain unclear. Therefore, the present study detected the expression of miR‑584 in NSCLC, investigated its role in NSCLC cells and determined its underlying molecular mechanism. In the current study, it was demonstrated that miR‑584 was downregulated in NSCLC tissues and cell lines. Low miR‑584 expression was correlated with tumour size, tumour node metastasis stage and distant metastasis. Overexpression of miR‑584 inhibited cell proliferation and invasion in NSCLC. Additionally, metadherin was identified as a direct target gene of miR‑584 in NSCLC as confirmed by a series of experiments. Moreover, upregulation of miR‑584 was involved in the regulation of the phosphatase and tensin homolog/Akt serine/threonine kinase signalling pathway in NSCLC. Thus, miR‑584 may serve as a tumor‑suppressor, and the results of the present study provide a reference for future research into the potential mechanisms underlying NSCLC progression.

Related Articles